PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $61,296 | -70.5% | 19,837 | -59.7% | 0.00% | -75.0% |
| Q4 2022 | $208,082 | +383.9% | 49,192 | +169.1% | 0.00% | +300.0% |
| Q3 2022 | $43,000 | -85.5% | 18,283 | -82.5% | 0.00% | -87.5% |
| Q2 2022 | $297,000 | -52.9% | 104,223 | -52.4% | 0.01% | -52.9% |
| Q1 2022 | $630,000 | -48.6% | 218,917 | -45.7% | 0.02% | -55.3% |
| Q4 2021 | $1,225,000 | +402.0% | 403,119 | +1350.1% | 0.04% | +137.5% |
| Q4 2019 | $244,000 | -35.6% | 27,800 | -6.7% | 0.02% | -61.9% |
| Q2 2019 | $379,000 | +205.6% | 29,800 | +1001.3% | 0.04% | -27.6% |
| Q3 2018 | $124,000 | – | 2,706 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |